vs
Foghorn Therapeutics Inc.（FHTX）与林德（LIN）财务数据对比。点击上方公司名可切换其他公司
Foghorn Therapeutics Inc.的季度营收约是林德的1.1倍（$9.2M vs $8.8M），Foghorn Therapeutics Inc.同比增速更快（223.8% vs 8.2%），过去两年Foghorn Therapeutics Inc.的营收复合增速更高（35.3% vs -96.7%）
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
林德是全球知名跨国化工企业，按市场份额及营收计为全球最大工业气体供应商。公司1879年由德国科学家、工程师卡尔·冯·林德在德国威斯巴登创立，现总部位于英国沃金，在爱尔兰注册，2018年由原林德股份公司与1907年在美国成立的普莱克斯合并组建。
FHTX vs LIN — 直观对比
营收规模更大
FHTX
是对方的1.1倍
$8.8M
营收增速更快
FHTX
高出215.5%
8.2%
两年增速更快
FHTX
近两年复合增速
-96.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $9.2M | $8.8M |
| 净利润 | $-21.7M | — |
| 毛利率 | — | 48.5% |
| 营业利润率 | -258.2% | 27.8% |
| 净利率 | -234.3% | — |
| 营收同比 | 223.8% | 8.2% |
| 净利润同比 | -11.1% | — |
| 每股收益（稀释后） | $-0.35 | $3.98 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FHTXLIN
| Q1 26 | — | $8.8M | ||
| Q4 25 | $9.2M | $8.8B | ||
| Q3 25 | $8.2M | $8.6B | ||
| Q2 25 | $7.6M | $8.5B | ||
| Q1 25 | $6.0M | $8.1B | ||
| Q4 24 | $2.9M | $8.3B | ||
| Q3 24 | $7.8M | $8.4B | ||
| Q2 24 | $6.9M | $8.3B |
净利润FHTXLIN
| Q1 26 | — | — | ||
| Q4 25 | $-21.7M | $1.5B | ||
| Q3 25 | $-15.8M | $1.9B | ||
| Q2 25 | $-17.9M | $1.8B | ||
| Q1 25 | $-18.8M | $1.7B | ||
| Q4 24 | $-19.5M | $1.7B | ||
| Q3 24 | $-19.1M | $1.6B | ||
| Q2 24 | $-23.0M | $1.7B |
毛利率FHTXLIN
| Q1 26 | — | 48.5% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
营业利润率FHTXLIN
| Q1 26 | — | 27.8% | ||
| Q4 25 | -258.2% | 23.0% | ||
| Q3 25 | -226.9% | 27.5% | ||
| Q2 25 | -279.2% | 27.7% | ||
| Q1 25 | -385.0% | 26.9% | ||
| Q4 24 | -840.5% | 27.4% | ||
| Q3 24 | -305.5% | 25.0% | ||
| Q2 24 | -386.6% | 26.4% |
净利率FHTXLIN
| Q1 26 | — | — | ||
| Q4 25 | -234.3% | 17.5% | ||
| Q3 25 | -194.4% | 22.4% | ||
| Q2 25 | -237.3% | 20.8% | ||
| Q1 25 | -316.4% | 20.6% | ||
| Q4 24 | -682.9% | 20.8% | ||
| Q3 24 | -244.9% | 18.5% | ||
| Q2 24 | -333.6% | 20.1% |
每股收益（稀释后）FHTXLIN
| Q1 26 | — | $3.98 | ||
| Q4 25 | $-0.35 | $3.28 | ||
| Q3 25 | $-0.25 | $4.09 | ||
| Q2 25 | $-0.28 | $3.73 | ||
| Q1 25 | $-0.30 | $3.51 | ||
| Q4 24 | $-0.23 | $3.61 | ||
| Q3 24 | $-0.31 | $3.22 | ||
| Q2 24 | $-0.45 | $3.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.9M | $4.0M |
| 总债务越低越好 | — | $24.7M |
| 股东权益账面价值 | $-108.5M | $40.1M |
| 总资产 | $198.1M | $86.3M |
| 负债/权益比越低杠杆越低 | — | 0.62× |
8季度趋势，按日历期对齐
现金及短期投资FHTXLIN
| Q1 26 | — | $4.0M | ||
| Q4 25 | $80.9M | $5.1B | ||
| Q3 25 | $89.3M | $4.5B | ||
| Q2 25 | $72.6M | $4.8B | ||
| Q1 25 | $61.0M | $5.3B | ||
| Q4 24 | $55.5M | $4.8B | ||
| Q3 24 | $57.7M | $5.2B | ||
| Q2 24 | $138.9M | $4.6B |
总债务FHTXLIN
| Q1 26 | — | $24.7M | ||
| Q4 25 | — | $20.7B | ||
| Q3 25 | — | $18.6B | ||
| Q2 25 | — | $19.7B | ||
| Q1 25 | — | $17.6B | ||
| Q4 24 | — | $15.3B | ||
| Q3 24 | — | $17.5B | ||
| Q2 24 | — | $16.9B |
股东权益FHTXLIN
| Q1 26 | — | $40.1M | ||
| Q4 25 | $-108.5M | $38.2B | ||
| Q3 25 | $-89.7M | $38.6B | ||
| Q2 25 | $-76.7M | $38.5B | ||
| Q1 25 | $-61.7M | $38.0B | ||
| Q4 24 | $-45.5M | $38.1B | ||
| Q3 24 | $-28.3M | $39.2B | ||
| Q2 24 | $-14.3M | $38.2B |
总资产FHTXLIN
| Q1 26 | — | $86.3M | ||
| Q4 25 | $198.1M | $86.8B | ||
| Q3 25 | $205.0M | $86.0B | ||
| Q2 25 | $226.2M | $86.1B | ||
| Q1 25 | $258.7M | $82.7B | ||
| Q4 24 | $284.0M | $80.1B | ||
| Q3 24 | $308.4M | $82.5B | ||
| Q2 24 | $328.6M | $80.2B |
负债/权益比FHTXLIN
| Q1 26 | — | 0.62× | ||
| Q4 25 | — | 0.54× | ||
| Q3 25 | — | 0.48× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 0.46× | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | 0.45× | ||
| Q2 24 | — | 0.44× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.3M | — |
| 自由现金流经营现金流 - 资本支出 | — | $898.0K |
| 自由现金流率自由现金流/营收 | — | 10.2% |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $4.2B |
8季度趋势，按日历期对齐
经营现金流FHTXLIN
| Q1 26 | — | — | ||
| Q4 25 | $-22.3M | $3.0B | ||
| Q3 25 | $-18.9M | $2.9B | ||
| Q2 25 | $-21.0M | $2.2B | ||
| Q1 25 | $-24.0M | $2.2B | ||
| Q4 24 | $-24.5M | $2.8B | ||
| Q3 24 | $-21.0M | $2.7B | ||
| Q2 24 | $-25.5M | $1.9B |
自由现金流FHTXLIN
| Q1 26 | — | $898.0K | ||
| Q4 25 | — | $1.6B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | $-21.0M | $954.0M | ||
| Q1 25 | $-24.0M | $891.0M | ||
| Q4 24 | $-25.0M | $1.6B | ||
| Q3 24 | $-21.3M | $1.7B | ||
| Q2 24 | $-25.6M | $796.0M |
自由现金流率FHTXLIN
| Q1 26 | — | 10.2% | ||
| Q4 25 | — | 17.9% | ||
| Q3 25 | — | 19.4% | ||
| Q2 25 | -278.2% | 11.2% | ||
| Q1 25 | -403.2% | 11.0% | ||
| Q4 24 | -875.3% | 18.8% | ||
| Q3 24 | -273.0% | 19.9% | ||
| Q2 24 | -371.0% | 9.6% |
资本支出强度FHTXLIN
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 16.6% | ||
| Q3 25 | 0.0% | 14.8% | ||
| Q2 25 | 0.3% | 14.8% | ||
| Q1 25 | 0.5% | 15.7% | ||
| Q4 24 | 16.8% | 15.1% | ||
| Q3 24 | 4.0% | 12.8% | ||
| Q2 24 | 0.2% | 13.7% |
现金转化率FHTXLIN
| Q1 26 | — | — | ||
| Q4 25 | — | 1.98× | ||
| Q3 25 | — | 1.53× | ||
| Q2 25 | — | 1.25× | ||
| Q1 25 | — | 1.29× | ||
| Q4 24 | — | 1.63× | ||
| Q3 24 | — | 1.76× | ||
| Q2 24 | — | 1.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
